politics
A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs
Archived — last updated
Rasonque, the new pancreatic cancer treatment from Revolution Medicines, illustrates the huge inflation in cancer drug prices over the past two decades.
Latest updates
No updates on this story yet.
AI-assisted summary of the reporting above. Quotes are kept to one sentence. Copyright concern? See our DMCA takedown page.
